Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve Approval of Unaudited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sandu Pharmaceuticals has informed BSE that its Board of Directors will meet on 13 August 2025 at 3:00 p.m. at its corporate office in Chembur, Mumbai. The main agenda is to consider and approve the standalone unaudited financial results for the quarter ended 30 June 2025 (Q1 FY26). The company also noted it has no subsidiaries, so no consolidated results are required. The trading window for insiders has been closed from 1 July 2025 until 48 hours after the results are publicly announced.
This is a routine procedural filing and does not contain any financial figures or business updates. Investors should wait for the actual Q1 results on or after 13 August 2025 to gauge any meaningful impact on the stock.